Work

The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity

Year: 2010

Type: article

Source: Investigational New Drugs

DOI: 10.1007/s10637-010-9542-z

Authors: Nataly Tarasenko, Gania Kessler-Icekson, Pnina Boer, Aida Inbal, Hadassa Schlesinger, Don R. Phillips, Suzanne M. Cutts, Abraham Nudelman, Ada Rephaeli

Institutions: Tel Aviv University, Rabin Medical Center, La Trobe University, Bar-Ilan University

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Teva Pharmaceutical Industries, Bar-Ilan University, Israel Cancer Association, National Institutes of Health

OpenAlex ID: W1964657906

FWCI: 0.861

Cites: 43

Cited by: 39

Related to: 10